Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Bristol Myers Squibb Company (BMY) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 1.7× (July 2024) to 7.3× (June 2016); the current reading is higher than 20% of that period. That is below the Drug Manufacturers General industry median of 3.4× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.3× (4.09%)
FY2024 2.4× (2.14%)
FY2023 2.4× (27.26%)
FY2022 3.3× 11.69%
FY2021 3.0× (9.37%)
FY2020 3.3× (21.30%)
FY2019 4.2× 11.26%
FY2018 3.8× (22.50%)
FY2017 4.9× (5.07%)
FY2016 5.1× (26.15%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 2.4× (6.17%)
Mar 2026 2.5× 11.99%
Dec 2025 2.3× 19.09%
Sep 2025 1.9× (3.20%)
42 more quarters

Against its own ten years

Low 1.7× High 7.3×
Ten-year median 3.4×
Current reading's percentile 22

P/S ratio against peers

Company P/S ratio
SNY Sanofi compare 1.7×
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company 2.5×
PFE Pfizer Inc. compare 2.6×
NVO Novo Nordisk A/S compare 3.3×
AZN AstraZeneca PLC compare 4.2×
NVS Novartis AG compare 5.1×
AMGN Amgen Inc. compare 6.1×
GILD Gilead Sciences, Inc. compare 6.4×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on BMY